GT Biopharma Inc (GTBP) financials · $17.4M cap
GT Biopharma Inc (GTBP) $17.4M cap.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Income | -$12.4M | -$14.4M | -$13.6M |
| Net Income | -$28.4M | -$13.2M | -$7.6M |
| EPS (Diluted) | $-7.00 | $-7.00 | $-6.00 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | $8.1M | $4.2M | $14.1M |
| Current Assets | $8.1M | $4.2M | $0 |
| Cash & Equivalents | $6.8M | $4.0M | $1.1M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $8.1M | $4.2M | $6.6M |
| Current Liabilities | $2.3M | $5.9M | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $5.8M | -$1.7M | $0 |
| Retained Earnings | -$723.9M | -$695.2M | $0 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.9M | -$12.9M |
| CapEx | $0 | $0 |
| Investing Cash Flow | $0 | $12.9M |
| Financing Cash Flow | $15.8M | $3.0M |
| Dividends Paid | $229.0K | $0 |
| Net Change in Cash | $2.9M | $0 |
| Free Cash Flow | $0 | $0 |
FAQ
What is GTBP P/E and revenue?
GT Biopharma Inc (GTBP) $17.4M cap.
What is GTBP revenue?
GT Biopharma Inc last cached revenue is $0 (FY2025).
Is GTBP profitable?
GT Biopharma Inc last cached net income is -$28.4M.
What are GTBP total assets?
GT Biopharma Inc last cached total assets are $8.1M.
What is GTBP free cash flow?
GT Biopharma Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.